• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 15, 2023

    3/15/23 9:41:03 AM ET
    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Computer Software: Prepackaged Software
    Technology
    Major Chemicals
    Industrials
    Get the next $ADBE alert in real time by email

    Companies Reporting Before The Bell

    • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

    • InfuSystems Holdings (AMEX:INFU) is projected to report quarterly earnings at $0.04 per share on revenue of $30.80 million.

    • Kandi Technologies Gr (NASDAQ:KNDI) is projected to report quarterly earnings at $0.02 per share on revenue of $49.30 million.

    • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.34 per share on revenue of $341.25 million.

    • Calumet Specialty (NASDAQ:CLMT) is likely to report quarterly earnings at $0.00 per share on revenue of $904.43 million.

    • Oatly Group (NASDAQ:OTLY) is likely to report quarterly loss at $0.14 per share on revenue of $181.52 million.

    • Ebix (NASDAQ:EBIX) is estimated to report quarterly earnings at $0.54 per share on revenue of $251.04 million.

    • Ucloudlink Group (NASDAQ:UCL) is projected to report quarterly loss at $0.08 per share on revenue of $20.20 million.

    • Kamada (NASDAQ:KMDA) is estimated to report quarterly earnings at $0.06 per share on revenue of $44.64 million.

    • Star Equity Hldgs (NASDAQ:STRR) is projected to report quarterly loss at $0.02 per share on revenue of $28.75 million.

    • Waldencast (NASDAQ:WALD) is likely to report quarterly loss at $0.01 per share on revenue of $51.55 million.

    • HOOKIPA Pharma (NASDAQ:HOOK) is likely to report quarterly loss at $0.21 per share on revenue of $7.07 million.

    • Ranpak Hldgs (NYSE:PACK) is likely to report quarterly loss at $0.09 per share on revenue of $90.48 million.

    • Circor Intl (NYSE:CIR) is likely to report quarterly earnings at $0.39 per share on revenue of $204.00 million.

    • Charge Enterprises (NASDAQ:CRGE) is likely to report quarterly loss at $0.05 per share on revenue of $190.32 million.

    • Arcos Dorados Holdings (NYSE:ARCO) is projected to report quarterly earnings at $0.23 per share on revenue of $990.25 million.

    • Silence Therapeutics (NASDAQ:SLN) is estimated to report earnings for its fourth quarter.

    • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.05 per share on revenue of $229.72 million.

    • BRC (NYSE:BRCC) is projected to report quarterly loss at $0.07 per share on revenue of $92.39 million.

    • BrainsWay (NASDAQ:BWAY) is estimated to report quarterly loss at $0.13 per share on revenue of $6.20 million.

    • Enlight Renewable Energy (NASDAQ:ENLT) is estimated to report earnings for its fourth quarter.

    • KNOT Offshore Partners (NYSE:KNOP) is likely to report quarterly earnings at $0.17 per share on revenue of $69.03 million.

    • Chindata Group Holdings (NASDAQ:CD) is projected to report earnings for its fourth quarter.

    • Audacy (NYSE:AUD) is estimated to report quarterly earnings at $0.07 per share on revenue of $344.12 million.

    Companies Reporting After The Bell

    • RCM Technologies (NASDAQ:RCMT) is projected to report quarterly earnings at $0.47 per share on revenue of $68.88 million.

    • Sigilon Therapeutics (NASDAQ:SGTX) is likely to report quarterly loss at $0.38 per share on revenue of $2.67 million.

    • Zedge (AMEX:ZDGE) is projected to report quarterly loss at $0.11 per share on revenue of $7.03 million.

    • IMV (NASDAQ:IMV) is estimated to report quarterly loss at $1.64 per share on revenue of $40 thousand.

    • Proterra (NASDAQ:PTRA) is likely to report quarterly loss at $0.25 per share on revenue of $86.85 million.

    • LivePerson (NASDAQ:LPSN) is likely to report quarterly loss at $0.35 per share on revenue of $126.96 million.

    • Liminal Biosciences (NASDAQ:LMNL) is projected to report earnings for its fourth quarter.

    • Champions Oncology (NASDAQ:CSBR) is projected to report quarterly loss at $0.03 per share on revenue of $13.13 million.

    • Senseonics Holdings (AMEX:SENS) is expected to report earnings for its fourth quarter.

    • VolitionRX (AMEX:VNRX) is projected to report quarterly loss at $0.15 per share on revenue of $220 thousand.

    • Legacy Housing (NASDAQ:LEGH) is projected to report quarterly earnings at $0.60 per share on revenue of $60.63 million.

    • JOYY (NASDAQ:YY) is projected to report quarterly earnings at $0.24 per share on revenue of $599.90 million.

    • Groupon (NASDAQ:GRPN) is estimated to report quarterly loss at $0.40 per share on revenue of $161.55 million.

    • Franco-Nevada (NYSE:FNV) is expected to report quarterly earnings at $1.15 per share on revenue of $419.59 million.

    • UiPath (NYSE:PATH) is projected to report quarterly earnings at $0.06 per share on revenue of $278.62 million.

    • Owlet (NYSE:OWLT) is expected to report quarterly loss at $0.15 per share on revenue of $12.92 million.

    • Array Technologies (NASDAQ:ARRY) is expected to report quarterly earnings at $0.08 per share on revenue of $366.77 million.

    • Catalyst Pharmaceuticals (NASDAQ:CPRX) is expected to report quarterly earnings at $0.21 per share on revenue of $58.09 million.

    • Tutor Perini (NYSE:TPC) is estimated to report quarterly earnings at $0.01 per share on revenue of $976.17 million.

    • Matinas BioPharma Hldgs (AMEX:MTNB) is projected to report quarterly loss at $0.03 per share on revenue of $1.07 million.

    • MorphoSys (NASDAQ:MOR) is projected to report quarterly loss at $0.44 per share on revenue of $80.01 million.

    • FG Group Holdings (AMEX:FGH) is expected to report earnings for its fourth quarter.

    • Vaxart (NASDAQ:VXRT) is likely to report quarterly loss at $0.23 per share on revenue of $670 thousand.

    • AEye (NASDAQ:LIDR) is projected to report quarterly loss at $0.15 per share on revenue of $1.02 million.

    • SuRo Capital (NASDAQ:SSSS) is estimated to report earnings for its fourth quarter.

    • Inspirato (NASDAQ:ISPO) is projected to report quarterly loss at $0.15 per share on revenue of $80.77 million.

    • Capricor Therapeutics (NASDAQ:CAPR) is estimated to report earnings for its fourth quarter.

    • Zomedica (AMEX:ZOM) is expected to report earnings for its fourth quarter.

    • Cyngn (NASDAQ:CYN) is estimated to report earnings for its fourth quarter.

    • Macrogenics (NASDAQ:MGNX) is estimated to report earnings for its fourth quarter.

    • Park-Ohio Hldgs (NASDAQ:PKOH) is expected to report quarterly earnings at $0.46 per share on revenue of $427.10 million.

    • Pangaea Logistics Solns (NASDAQ:PANL) is projected to report quarterly earnings at $0.29 per share on revenue of $157.20 million.

    • Superior Gr of Cos (NASDAQ:SGC) is expected to report quarterly earnings at $0.07 per share on revenue of $143.70 million.

    • Hesai Gr (NASDAQ:HSAI) is projected to report earnings for its first quarter.

    • Brilliant Earth Group (NASDAQ:BRLT) is expected to report quarterly earnings at $0.05 per share on revenue of $123.39 million.

    • Mineralys Therapeutics (NASDAQ:MLYS) is estimated to report earnings for its fourth quarter.

    • ToughBuilt Industries (NASDAQ:TBLT) is expected to report earnings for its fourth quarter.

    • IDW Media Holdings (AMEX:IDW) is projected to report earnings for its first quarter.

    • Fluent (NASDAQ:FLNT) is projected to report quarterly loss at $0.01 per share on revenue of $89.27 million.

    • CTS (NYSE:CTS) is likely to report quarterly earnings at $0.10 per share on revenue of $774.58 million.

    • Avinger (NASDAQ:AVGR) is likely to report earnings for its fourth quarter.

    • Fortuna Silver Mines (NYSE:FSM) is likely to report earnings for its fourth quarter.

    • Cue Health (NASDAQ:HLTH) is likely to report quarterly loss at $0.45 per share on revenue of $47.77 million.

    • Five Below (NASDAQ:FIVE) is estimated to report quarterly earnings at $3.06 per share on revenue of $1.11 billion.

    • Natures Sunshine Products (NASDAQ:NATR) is expected to report quarterly loss at $0.04 per share on revenue of $100.26 million.

    • Ontrak (NASDAQ:OTRK) is estimated to report quarterly loss at $0.55 per share on revenue of $3.00 million.

    • Northwest Pipe (NASDAQ:NWPX) is likely to report quarterly earnings at $0.71 per share on revenue of $109.35 million.

    • Cadre Hldgs (NYSE:CDRE) is expected to report quarterly earnings at $0.21 per share on revenue of $115.70 million.

    • ZTO Express (Cayman) (NYSE:ZTO) is projected to report quarterly earnings at $0.37 per share on revenue of $1.47 billion.

    • Ideanomics (NASDAQ:IDEX) is estimated to report quarterly loss at $0.08 per share on revenue of $48.80 million.

    • Boxlight (NASDAQ:BOXL) is estimated to report quarterly loss at $0.05 per share on revenue of $48.06 million.

    • EverCommerce (NASDAQ:EVCM) is projected to report quarterly earnings at $0.08 per share on revenue of $157.97 million.

    • MaxCyte (NASDAQ:MXCT) is likely to report quarterly loss at $0.07 per share on revenue of $12.90 million.

    • Adobe (NASDAQ:ADBE) is expected to report quarterly earnings at $3.68 per share on revenue of $4.62 billion.

    • Alpha Teknova (NASDAQ:TKNO) is projected to report quarterly loss at $0.34 per share on revenue of $7.72 million.

    • Amyris (NASDAQ:AMRS) is expected to report quarterly loss at $0.27 per share on revenue of $104.10 million.

    • GrowGeneration (NASDAQ:GRWG) is likely to report quarterly loss at $0.11 per share on revenue of $51.78 million.

    • NACCO Industries (NYSE:NC) is estimated to report earnings for its fourth quarter.

    • PagerDuty (NYSE:PD) is expected to report quarterly earnings at $0.02 per share on revenue of $98.84 million.

    • NuScale Power (NYSE:SMR) is projected to report quarterly loss at $0.02 per share on revenue of $5.00 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $AMRS
    $ARCO
    $ARRY

    CompanyDatePrice TargetRatingAnalyst
    NuScale Power Corporation
    $SMR
    2/27/2026$21.00Market Perform → Outperform
    Northland Capital
    Array Technologies Inc.
    $ARRY
    2/26/2026$9.00Buy → Hold
    Deutsche Bank
    Array Technologies Inc.
    $ARRY
    2/25/2026$19.00Neutral → Outperform
    BNP Paribas Exane
    NuScale Power Corporation
    $SMR
    2/11/2026Buy → Hold
    TD Cowen
    Hesai Group
    $HSAI
    2/10/2026$31.50Outperform
    Macquarie
    ZTO Express (Cayman) Inc.
    $ZTO
    2/9/2026$26.60Neutral → Outperform
    Macquarie
    Park-Ohio Holdings Corp.
    $PKOH
    2/9/2026$37.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Five Below Inc.
    $FIVE
    2/4/2026$233.00Underperform → Buy
    BofA Securities
    More analyst ratings

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Eberwein Jeffrey E. sold $39,794 worth of Series A Preferred Stock (4,365 units at $9.12) and bought $81,503 worth of shares (7,268 units at $11.21), increasing direct ownership by 27% to 1,007,824 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/31/25 5:02:24 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Eberwein Jeffrey E. sold $173,974 worth of Series A Preferred Stock (18,635 units at $9.34) and bought $109,212 worth of shares (9,709 units at $11.25), increasing direct ownership by 23% to 1,000,556 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/29/25 7:09:34 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Eberwein Jeffrey E. bought $2,999,991 worth of shares (287,631 units at $10.43) and sold $2,999,994 worth of Series A Preferred Stock (320,855 units at $9.35), increasing direct ownership by 15% to 810,217 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/10/25 4:01:17 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NuScale Power upgraded by Northland Capital with a new price target

    Northland Capital upgraded NuScale Power from Market Perform to Outperform and set a new price target of $21.00

    2/27/26 8:22:27 AM ET
    $SMR
    Metal Fabrications
    Industrials

    Array Tech downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Array Tech from Buy to Hold and set a new price target of $9.00

    2/26/26 7:10:22 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Array Tech upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded Array Tech from Neutral to Outperform and set a new price target of $19.00

    2/25/26 7:19:45 AM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 6, 2023 - FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

    For Immediate Release: June 06, 2023 Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. This test is the first at-home over-the-c

    6/6/23 3:04:14 PM ET
    $HLTH
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA

    Submission status for MACROGENICS INC's drug MARGENZA (ORIG-1) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 12/16/2020. Application Category: BLA, Application Number: 761150, Application Classification:

    12/20/20 4:31:01 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

    NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), today announced Schweiger Dermatology as a key partner for the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program. Schweiger will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple trials and evaluation programs. "This partnership with Obagi makes perfect sense for us. They're taking a thoughtful, evidence-based approach to introducing this innovative injectable, and we

    2/27/26 8:33:00 AM ET
    $WALD
    Package Goods/Cosmetics
    Consumer Discretionary

    LivePerson Named a Leader in the Aragon Research Globe™ for Agent Platforms 2026

    The conversational AI and AI agent evaluation platform was recognized alongside other major platformsNEW YORK, Feb. 27, 2026 /PRNewswire/ -- LivePerson (NASDAQ:LPSN), a leading provider of predictable conversational AI, today announced Aragon Research, Inc. has positioned LivePerson in the Leader section of "The Aragon Research Globe™ for Agent Platforms, 2026," a report that evaluates 21 major providers of AI agent platforms and examines the shift from chatbot to sophisticated AI agent systems. "We believe our positioning as a Leader in the Aragon Research Globe confirms our co

    2/27/26 8:00:00 AM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    Super Technologies Strengthens Sportradar Partnership to Accelerate Its Global Growth Strategy

    ST. GALLEN, Switzerland, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Super Technologies (Super), through their leading commercial brand Superbet, has deepened its long-standing relationship with Sportradar AG (NASDAQ:SRAD), signing a unique agreement aimed at supercharging the global entertainment brand's growth by unlocking the full suite of Sportradar's value add betting solutions. Super gains access to a wide array of products from Sportradar's market leading betting portfolio in return for committed annual spend. The client-centric approach provides Super the flexibility to adjust products in order to meet continually evolving business needs. Sportradar will enhance the sports betting experien

    2/27/26 8:00:00 AM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rubin Ethel was granted 178,000 shares, increasing direct ownership by 237% to 252,948 units (SEC Form 4)

    4 - VOLITIONRX LTD (0000093314) (Issuer)

    2/27/26 4:32:24 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Secretary Rootsaert Rodney Gerard was granted 119,000 shares, increasing direct ownership by 73% to 281,262 units (SEC Form 4)

    4 - VOLITIONRX LTD (0000093314) (Issuer)

    2/27/26 4:31:25 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    President and CEO Reynolds Cameron John was granted 486,000 shares, increasing direct ownership by 18% to 3,115,547 units (SEC Form 4)

    4 - VOLITIONRX LTD (0000093314) (Issuer)

    2/27/26 4:32:03 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    SEC Filings

    View All

    InfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InfuSystem Holdings, Inc (0001337013) (Filer)

    2/27/26 4:54:04 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Arcos Dorados Holdings Inc.

    S-8 POS - Arcos Dorados Holdings Inc. (0001508478) (Filer)

    2/27/26 4:42:06 PM ET
    $ARCO
    Restaurants
    Consumer Discretionary

    SEC Form 10-K filed by InfuSystems Holdings Inc.

    10-K - InfuSystem Holdings, Inc (0001337013) (Filer)

    2/27/26 4:07:43 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    Arcos Dorados Holdings Inc. Fourth Quarter 2025 Results Webcast Date and Time

    Scheduled for: Thursday, March 19, 2026 10:00 a.m. New York / 11:00 a.m. Montevideo Arcos Dorados Holdings Inc. (NYSE:ARCO) will hold a webcast to discuss its results for the fourth quarter and full year ended December 31, 2025, which will be released before the market opens on Thursday, March 19, 2026. Luis Raganato, Chief Executive Officer, and senior management will host the webcast. Opening remarks will be followed by a question-and-answer period. Participants from the investment community will be able to join the webcast (Google Chrome is recommended) using the following link: Arcos Dorados Fourth Quarter 2025 Earnings Webcast. The link will also be available on the Events section

    2/19/26 7:15:00 AM ET
    $ARCO
    Restaurants
    Consumer Discretionary

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:53:36 PM ET
    $NC
    Coal Mining
    Energy

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:38:59 PM ET
    $NC
    Coal Mining
    Energy

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:38:47 PM ET
    $NC
    Coal Mining
    Energy

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Financials

    Live finance-specific insights

    View All

    Calumet Reports Fourth Quarter and Fiscal Year 2025 Results

    Fiscal Year 2025 net loss of $33.8 million, or basic loss per common share of $0.39Fiscal Year 2025 Adjusted EBITDA with Tax Attributes of $293.3 million$222 million of recourse debt reduction in 2025Strong free cash flow driven by approximately $100 million of cost reduction initiatives in 2025Record production year in Specialty Products & Solutions segment and Montana RenewablesMontana Renewables MaxSAF®150 expansion on track for second quarter of 2026INDIANAPOLIS, Feb. 27, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ:CLMT) (the "Company," "Calumet," "we," "our" or "us")  today reported its results for the fourth quarter and year ended December 31, 2025, as follows: Three Months Ended Decemb

    2/27/26 7:00:00 AM ET
    $CLMT
    Integrated oil Companies
    Energy

    ZTO to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on March 17, 2026 U.S. Eastern Time

    SHANGHAI, Feb. 27, 2026 /PRNewswire/ -- ZTO Express (Cayman) Inc. (NYSE:ZTO) ("ZTO" or the "Company"), a leading and fast-growing express delivery company in China, today announced that it will release its unaudited financial results for the fourth quarter ended December 31, 2025 and its unaudited annual results for the fiscal year ended December 31, 2025, after the U.S. market closes on March 17, 2026. ZTO's management team will host an earnings conference call at 8:30 P.M. U.S. Eastern Time on Tuesday, March 17, 2026, which is 8:30 A.M. Beijing Time on Wednesday, March 18, 2026.Dial-in details for the earnings conference call are as follows:United States/Canada:1-888-317-6003Hong Kong:800-

    2/27/26 7:00:00 AM ET
    $ZTO
    Trucking Freight/Courier Services
    Industrials

    Babcock & Wilcox Sets Fourth Quarter 2025 Conference Call and Webcast for Monday, March 16, 2026 at 5 p.m. ET

    Babcock & Wilcox Enterprises, Inc. (NYSE:BW) (B&W or the "Company") will host a conference call and webcast on Monday, March 16, 2026 at 5 p.m. ET. B&W Chairman and Chief Executive Officer Kenneth Young and B&W Chief Financial Officer Cameron Frymyer will discuss the Company's fourth quarter and full year 2025 results. The Company expects to issue a news release detailing the results prior to the March 16 conference call and webcast. The listen-only audio of the conference call will be broadcast live via the Internet on B&W's Investor Relations site. The dial-in number for participants in the U.S. is (833) 470-1428; the dial-in number for participants in Canada is (833) 950-0062; the di

    2/26/26 5:07:00 PM ET
    $BW
    Building Products
    Industrials